ORLY
48
-2
HUM
35
2
CPB
39
2
ORCL
37
3
MU
55
-5
LOW
62
4
LEG
61
-3
PEP
41
-4
NUE
54
-4
FTI
79
-3
MHK
46
-7
TRIP
60
2
DG
78
2
EXR
19
-3
JBHT
52
-3
MCK
63
-3
ABBV
50
-7
EMN
55
3
DUK
52
-3
GD
57
-3
ORLY
48
-2
HUM
35
2
CPB
39
2
ORCL
37
3
MU
55
-5
LOW
62
4
LEG
61
-3
PEP
41
-4
NUE
54
-4
FTI
79
-3
MHK
46
-7
TRIP
60
2
DG
78
2
EXR
19
-3
JBHT
52
-3
MCK
63
-3
ABBV
50
-7
EMN
55
3
DUK
52
-3
GD
57
-3
Financhill
Back

Cellectar Biosciences, Inc. 10K Form

Sell
37

CLRB
Cellectar Biosciences, Inc.

Last Price:
$3.75
Seasonality Move:
-8.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLRB News And Ratings

See the #1 stock for the next 7 days that we like better than CLRB

CLRB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-4.3M
Price / Cash Flow: 0
Annual Sales: $2.34
Price / Book: 0.91

Profitability

EPS (TTM): -6.46860
Net Income (TTM): $-18.9M
Gross Margin: $-291.7K
Return on Equity: -160.56%
Return on Assets: -87.98%

Cellectar Biosciences, Inc. Earnings Forecast

Key Cellectar Biosciences, Inc. Financial Ratios

  • Per Share Earnings over the last 23 years have been positive in 15 years.

Cellectar Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLRB
CUSIP: 15117F
Website: cellectar.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 2.77
Quick Ratio: 2.56

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLRB Technical Analysis vs Fundamental Analysis

Sell
37
Cellectar Biosciences, Inc. (CLRB) is a Sell

Is Cellectar Biosciences, Inc. a Buy or a Sell?